Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.60 USD
Change Today 0.00 / 0.00%
Volume 0.0
TIKRF On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

tikcro technologies ltd (TIKRF) Snapshot

Open
$0.60
Previous Close
$0.60
Day High
$0.60
Day Low
$0.60
52 Week High
07/1/15 - $0.74
52 Week Low
12/29/14 - $0.46
Market Cap
5.3M
Average Volume 10 Days
1.9K
EPS TTM
$-0.11
Shares Outstanding
8.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TIKCRO TECHNOLOGIES LTD (TIKRF)

Related News

No related news articles were found.

tikcro technologies ltd (TIKRF) Related Businessweek News

No Related Businessweek News Found

tikcro technologies ltd (TIKRF) Details

Tikcro Technologies Ltd. supports early stage biotechnology projects in Israel. It is involved in the development of antibodies that are selected and verified in pre-clinical trials with a focus on antibodies targeting the modulation of CTLA4 and PD1 cancer checkpoints. The company was formerly known as Tioga Technologies Ltd. and changed its name to Tikcro Technologies Ltd. in September 2003. Tikcro Technologies Ltd. was founded in 1999 and is based in Hadera, Israel.

tikcro technologies ltd (TIKRF) Top Compensated Officers

Chief Executive officer and Principal Financi...
Total Annual Compensation: $102.0K
Compensation as of Fiscal Year 2014.

tikcro technologies ltd (TIKRF) Key Developments

Tikcro Technologies Ltd. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Tikcro Technologies Ltd. reported unaudited earnings results for the second quarter and six months ended June 30, 2015. For the quarter, operating loss was $262,000 against $69,000 a year ago. Net loss was $267,000 or $0.03 per basic and diluted share against $92,000 or $0.01 per basic and diluted share a year ago. For the six months, operating loss was $426,000 against $187,000 a year ago. Net loss was $458,000 or $0.05 per basic and diluted share against $134,000 or $0.02 per basic and diluted share a year ago.

Tikcro Technologies Ltd. Announces to Proceed with CTLA4 and PD1 Antibody Generation Plan

Tikcro Technologies Ltd. announced that it will proceed with a pre-clinical plan for the generation and verification of new antibodies targeting the modulation of CTLA4 and PD1 cancer checkpoints. Based on a novel approach, it is expected that such new antibodies will be generated and validated throughout 2015. These antibodies are expected to have greater specificity and binding qualities over existing antibodies. CTLA4 and PD1 are acknowledged as key elements for harnessing a patient's own immune system in cancer treatments. Antibodies targeting these checkpoints were approved for clinical use. Interim clinical results show strong synergistic benefit for a combination treatment of such antibodies.

Tikcro Technologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2015

Tikcro Technologies Ltd. reported earnings results for the first quarter ended March 31, 2015. For the quarter, the company's operating loss was $164,000 against $118,000 a year ago. Net loss was $191,000 or $0.02 per basic and diluted share against $42,000 or $0.00 per basic and diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TIKRF:US $0.60 USD 0.00

TIKRF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TIKRF.
View Industry Companies
 

Industry Analysis

TIKRF

Industry Average

Valuation TIKRF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIKCRO TECHNOLOGIES LTD, please visit www.tikcro.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.